Kamada Ltd. (KMDA) Sank To Nearly A 5-Month Low

Kamada Ltd. (KMDA) announced Thursday morning that it has withdrawn its European Marketing Authorization Application for tis inhaled Alpha-1 Antitrypsin therapy.

from RTT - Before the Bell http://ift.tt/2s3gI3C
via IFTTT